share_log

HC Wainwright & Co. Maintains Buy on OKYO Pharma, Raises Price Target to $7

Moomoo 24/7 ·  Mar 22 11:05

HC Wainwright & Co. analyst Yi Chen maintains OKYO Pharma (NASDAQ:OKYO) with a Buy and raises the price target from $6 to $7.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment